SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:235757444"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:235757444" > aMMP-8 Oral Fluid P...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Sorsa, TKarolinska Institutet (author)

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-06-10
  • Frontiers Media SA,2022

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:235757444
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:235757444URI
  • https://doi.org/10.3389/froh.2022.897115DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The manuscript uses the previously published literature and highlights the benefits of active-matrix metalloproteinase (aMMP)-8 chairside/point-of-care (PoC) diagnostic tools as adjunctive measures in oral and systemic diseases. Previous studies suggest that as a biomarker, aMMP-8 is more precise than total MMP-8, MMP-9, MMP-2, MMP-3, MMP-13, MMP-7, MMP-1, calprotectin, myeloperoxidase (MPO), human neutrophil elastase (HNE), tissue inhibitor of matrix metalloproteinase (TIMP)-1, and bleeding of probing (BOP). Therefore, aMMP-8 could be implemented as the needed key biomarker for the new disease classification for both periodontitis and peri-implantitis. With a sensitivity to the tune of 75–85% and specificity in the range of 80–90%, lateral flow aMMP-8 PoC testing is comparable to catalytic protease activity assays for aMMP-8. The test can be further applied to estimate the glycemic status of an individual, to ascertain whether a person is at risk for COVID-19, in managing the oral side effects of radiotherapy carried in head and neck cancers, and in selected cases pertaining to reproductive health. In the future, aMMP-8 could find application as a potential systemic biomarker in diseases affecting the cardiovascular system, cancers, bacteremia, sepsis, diabetes, obesity, meningitis, as well as pancreatitis. The aMMP-8 PoCT is the first practical test in the emerging new dental clinical field, that is, oral clinical chemistry representing oral medicine, clinical chemistry, peri-implantology, and periodontology.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Nwhator, SO (author)
  • Sakellari, D (author)
  • Grigoriadis, A (author)
  • Umeizudike, KA (author)
  • Brandt, E (author)
  • Keskin, M (author)
  • Tervahartiala, T (author)
  • Pärnänen, P (author)
  • Gupta, S (author)
  • Mohindra, R (author)
  • Bostanci, NKarolinska Institutet (author)
  • Buduneli, N (author)
  • Räisänen, IT (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Frontiers in oral health: Frontiers Media SA3, s. 897115-2673-4842

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view